What is the recommended management for a 68-year-old man with situational anxiety after the death of a relative and insomnia who is taking hydroxyzine 10 mg at bedtime as needed, which improves anxiety but not sleep?

Recommendation for Sleep Management in Situational Anxiety

Initiate cognitive behavioral therapy for insomnia (CBT-I) as first-line treatment, and consider increasing the hydroxyzine dose to 25-50 mg at bedtime or switching to a short-term FDA-approved hypnotic agent (such as low-dose doxepin, zolpidem, or eszopiclone) if CBT-I is unavailable or unsuccessful. 1

Rationale and Clinical Approach

The American College of Physicians (2016) provides clear guidance: CBT-I should be the initial treatment for chronic insomnia disorder in all adults, including older patients 1. This is a strong recommendation based on moderate-quality evidence showing improved sleep onset latency, wake after sleep onset, sleep efficiency, and overall sleep quality 1. CBT-I can be delivered through multiple formats including individual therapy, group sessions, telephone/web-based modules, or self-help books, making it accessible even in primary care settings 1.

The Hydroxyzine Problem

Your patient's current regimen highlights a critical issue: hydroxyzine 10 mg is helping anxiety but not sleep. This is consistent with the evidence:

• A 2023 systematic review found only "mixed efficacy" for hydroxyzine in sleep measures, with studies using 25-100 mg doses 2
• The current 10 mg dose is below the therapeutic range studied for insomnia (25-50 mg minimum) 2
• Hydroxyzine is specifically cautioned against for acute treatment in older adults due to anticholinergic effects and safety concerns 3
• In elderly patients, hydroxyzine is considered "less useful for treatment of sleep disturbances" compared to other options 4

Specific Treatment Algorithm

Step 1: Address the Insomnia Properly

• Refer for CBT-I immediately (strong recommendation, moderate evidence) 1
• CBT-I components include: stimulus control (use bed only for sleep/sex), sleep restriction therapy, cognitive therapy, and sleep hygiene education 5, 1
• The American Academy of Sleep Medicine (2021) confirms CBT-I as first-line with clinically significant improvements in remission rate and sleep quality 5

Step 2: If CBT-I Alone Fails or Is Unavailable

Use shared decision-making to add pharmacotherapy 1. For this 68-year-old male:

Preferred options for older adults:

• Low-dose doxepin (3-6 mg): Improves sleep maintenance with moderate-quality evidence in older adults; FDA-approved 1, 6
• Zolpidem (5 mg in elderly): Decreases sleep onset latency with low-to-moderate quality evidence 1, 6
• Eszopiclone (1-2 mg in elderly): Improves both global and sleep outcomes in older adults 1, 6

If increasing hydroxyzine:

• Increase to 25-50 mg at bedtime (the studied therapeutic range) 2
• However, this is NOT preferred in a 68-year-old due to anticholinergic burden, risk of cognitive impairment, and falls 3

Step 3: Duration and Monitoring

• Pharmacotherapy should be SHORT-TERM only (4-5 weeks) per FDA approval 1
• Evidence is insufficient for long-term use of any hypnotic 1
• For situational insomnia related to bereavement, symptoms often improve as the acute stressor resolves 7

Critical Safety Considerations in This 68-Year-Old

Avoid or use extreme caution with:

• Benzodiazepines: Associated with dementia, serious injury, and fractures in observational studies 1
• Hydroxyzine at current or higher doses: Anticholinergic effects, QT prolongation risk, and limited efficacy data in elderly 8, 3
• Diphenhydramine/antihistamines: High anticholinergic burden in elderly 6

FDA warnings for hypnotics include: daytime impairment, sleep-driving, behavioral abnormalities, and worsening depression 1. Use lower doses than studied in trials, especially for older adults 1.

Addressing the Situational Anxiety Component

Since hydroxyzine IS helping the anxiety, you have two paths:

1. Continue hydroxyzine 10 mg for anxiety (it's working for this indication) + add a separate FDA-approved hypnotic for sleep 9
2. Switch to an SSRI (sertraline or escitalopram first-line for GAD in elderly) which addresses both anxiety and may improve sleep over time 3

For acute situational anxiety related to bereavement, short-term hydroxyzine for anxiety is reasonable 9, but do not rely on it for insomnia treatment in this age group 3.

Common Pitfalls to Avoid

• Don't continue ineffective treatment: 10 mg hydroxyzine clearly isn't addressing the sleep problem
• Don't assume higher doses of the wrong drug will work: Even at 25-50 mg, hydroxyzine has only mixed efficacy and carries risks in elderly 2, 3
• Don't skip CBT-I: It has the strongest evidence and no serious harms 1
• Don't use hypnotics long-term: Plan for discontinuation after 4-5 weeks 1